Stock Comparison Charts
Metric | ||||
---|---|---|---|---|
Stock Details | ||||
Current Price | 6930.0 | 603.55 | 219.72 | 159.32 |
Previous Close | 6876.0 | 584.2 | 219.61 | 159.3 |
Open | 6880.0 | 586.2 | 224.0 | 159.3 |
Day Low | 6870.0 | 586.2 | 218.71 | 158.4 |
Day High | 6939.5 | 615.0 | 224.0 | 159.8 |
Market Cap | 1839700115456.0 | 42493419520.0 | 2272168448.0 | 51702845440.0 |
P/E Ratio | 84.19 | 30.97 | 998.73 | N/A |
Forward P/E | 123.09 | N/A | N/A | 2.88 |
Earnings Per Share | 82.31 | 19.49 | 0.22 | -10.56 |
Dividend Yield (%) | 0.44 | N/A | N/A | N/A |
Beta | 0.34 | 0.07 | -0.18 | 0.41 |
EBITDA | 29680001024.0 | 2648600064.0 | 175184000.0 | -3231399936.0 |
Book Value | 563.71 | 347.9 | 58.16 | -6.68 |
Debt to Equity | 0.03 | 18.76 | 40.91 | N/A |
ROCE (%) | N/A | N/A | N/A | N/A |
ROE (%) | N/A | N/A | N/A | N/A |
Face Value | N/A | N/A | N/A | N/A |
Price to Book | 12.29 | 1.73 | 3.78 | -23.85 |
Performance | ||||
1Y Return (%) | 4851.93 | 949.3 | -1199.76 | -3664.24 |
About Company | ||||
Founded Year | N/A | N/A | N/A | N/A |
Employees | N/A | N/A | N/A | N/A |
Website | Live Website of DIVISLAB | Live Website of UNICHEMLAB | Live Website of NATCAPSUQ | Live Website of SPARC |
Company Overviews & Financial Position
Review detailed company profiles, including business summaries and key insights into their balance sheet and company financial position to aid in buying or selling decisions.
Divi's Laboratories Limited
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.
Unichem Laboratories Limited
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. Unichem Laboratories Limited was founded in 1944 and is based in Mumbai, India.
Natural Capsules Limited
Natural Capsules Limited engages in manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally. The company offers bovine spongiform encephalopathy and transmissible spongiform encephalopathy free gelatin, shiny gelatin, sodium lauryl sulfate free gelatin, halal certified gelatin, fast release gelatin, printed gelatin/cellulose, vegetarian, and enteric capsule shells. It is also involved in formulating pharmaceutical dosage forms in capsule dosage form. The company also exports its products. Natural Capsules Limited was incorporated in 1993 and is based in Bengaluru, India.
Sun Pharma Advanced Research Company Limited
Sun Pharma Advanced Research Company Limited, a clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology, neurodegeneration, and Immunology. The company's products under development include Elepsia XR for the treatment of epilepsy; PDP-716 for the treatment of open-angle glaucoma; and Sezaby for the treatment of neonatal seizures. In addition, it is developing Vodobatinib (SCC-138), a c-ABL inhibitor, which is in phase 2 clinical trial to treat Parkinson's disease; has completed phase 1 clinical trial for the treatment of lewy body dementia; and in preclinical trial to treat alzheimer's disease. Further, the company develops Vodobatinib (SCO-088), a BCR-ABL inhibitor, for the treatment of refractory chronic myelogenous leukemia that is in phase 2 clinical trial; and Vibozilimod (SCD-044), a selective sphingosine-1-phosphate receptor 1 (S1PR1) agonist, for the treatment of psoriasis and atopic dermatitis that is in phase 2 clinical trial. Additionally, it is developing SCD-153 for the treatment of alopecia areata and SBO-154, an anti-MUC-1 ADC, for the treatment of multiple tumors that is in preclinical trials. The company was incorporated in 2006 and is based in Mumbai, India.
Start Investing Today
Use a demat account and trading account to start buying or selling stocks in the stock market. Compare share prices and analyze financial statements to make informed investment decisions.
You May Be Interested In
Sun Pharmaceutical Industries Limited
Healthcare • Drug Manufacturers - Specialty & Generic
Cipla Limited
Healthcare • Drug Manufacturers - Specialty & Generic
Torrent Pharmaceuticals Limited
Healthcare • Drug Manufacturers - Specialty & Generic
Dr. Reddy's Laboratories Limited
Healthcare • Drug Manufacturers - Specialty & Generic
Zydus Lifesciences Limited
Healthcare • Drug Manufacturers - Specialty & Generic
Mankind Pharma Limited
Healthcare • Drug Manufacturers - Specialty & Generic
Lupin Limited
Healthcare • Drug Manufacturers - Specialty & Generic
Abbott India Limited
Healthcare • Drug Manufacturers - Specialty & Generic
Aurobindo Pharma Limited
Healthcare • Drug Manufacturers - Specialty & Generic
Alkem Laboratories Limited
Healthcare • Drug Manufacturers - Specialty & Generic